Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Ginsberg

Showing results (571-580 of 607) with videos related to

Pageof 61
Sort By:
Journal of the American Chemical Society|June 16, 2026
Atomic Alignment in PbS Nanocrystal Superlattices with Compact Inorganic Ligands via Reversible Oriented Attachment of NanocrystalsAhhyun Jeong, Aditya N Singh, Josh Portner, et al.
Annals of Internal Medicine|January 7, 2015
D-dimer testing to select patients with a first unprovoked venous thromboembolism who can stop anticoagulant therapy: a cohort studyClive Kearon, Frederick A Spencer, Denis O'Keeffe, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 10, 2012
Phase II trial of temozolomide in patients with relapsed sensitive or refractory small cell lung cancer, with assessment of methylguanine-DNA methyltransferase as a potential biomarkerM Catherine Pietanza, Kyuichi Kadota, Kety Huberman, et al.
Annals of Internal Medicine|June 7, 2006
An evaluation of D-dimer in the diagnosis of pulmonary embolism: a randomized trialClive Kearon, Jeffrey S Ginsberg, James Douketis, et al.
Thrombosis and Haemostasis|June 12, 1999
Safety of low-molecular-weight heparin in pregnancy: a systematic reviewB J Sanson, A W Lensing, M H Prins, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 7, 2005
Activity of SU11248, a multitargeted inhibitor of vascular endothelial growth factor receptor and platelet-derived growth factor receptor, in patients with metastatic renal cell carcinomaRobert J Motzer, M Dror Michaelson, Bruce G Redman, et al.
Journal of Thrombosis and Haemostasis : JTH|May 5, 2005
Does the type of hormone replacement therapy influence the risk of deep vein thrombosis? A prospective case-control studyJ D Douketis, J A Julian, C Kearon, et al.
JTO Clinical and Research Reports|January 5, 2022
Phase 1 Clinical Trial of Trametinib and Ponatinib in Patients With NSCLC Harboring <i>KRAS</i> MutationsKathryn C Arbour, Eusebio Manchado, Matthew J Bott, et al.
Thrombosis Research|June 30, 2016
D-dimer levels and recurrence in patients with unprovoked VTE and a negative qualitative D-dimer test after treatmentC Kearon, S Parpia, F A Spencer, et al.
The New England Journal of Medicine|August 15, 2003
Comparison of low-intensity warfarin therapy with conventional-intensity warfarin therapy for long-term prevention of recurrent venous thromboembolismClive Kearon, Jeffrey S Ginsberg, Michael J Kovacs, et al.
Pageof 61

Showing results (571-580 of 607) with videos related to

Sort By:
Pageof 61
Journal of the American Chemical Society|June 16, 2026
Atomic Alignment in PbS Nanocrystal Superlattices with Compact Inorganic Ligands via Reversible Oriented Attachment of NanocrystalsAhhyun Jeong, Aditya N Singh, Josh Portner, et al.
Annals of Internal Medicine|January 7, 2015
D-dimer testing to select patients with a first unprovoked venous thromboembolism who can stop anticoagulant therapy: a cohort studyClive Kearon, Frederick A Spencer, Denis O'Keeffe, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 10, 2012
Phase II trial of temozolomide in patients with relapsed sensitive or refractory small cell lung cancer, with assessment of methylguanine-DNA methyltransferase as a potential biomarkerM Catherine Pietanza, Kyuichi Kadota, Kety Huberman, et al.
Annals of Internal Medicine|June 7, 2006
An evaluation of D-dimer in the diagnosis of pulmonary embolism: a randomized trialClive Kearon, Jeffrey S Ginsberg, James Douketis, et al.
Thrombosis and Haemostasis|June 12, 1999
Safety of low-molecular-weight heparin in pregnancy: a systematic reviewB J Sanson, A W Lensing, M H Prins, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 7, 2005
Activity of SU11248, a multitargeted inhibitor of vascular endothelial growth factor receptor and platelet-derived growth factor receptor, in patients with metastatic renal cell carcinomaRobert J Motzer, M Dror Michaelson, Bruce G Redman, et al.
Journal of Thrombosis and Haemostasis : JTH|May 5, 2005
Does the type of hormone replacement therapy influence the risk of deep vein thrombosis? A prospective case-control studyJ D Douketis, J A Julian, C Kearon, et al.
JTO Clinical and Research Reports|January 5, 2022
Phase 1 Clinical Trial of Trametinib and Ponatinib in Patients With NSCLC Harboring <i>KRAS</i> MutationsKathryn C Arbour, Eusebio Manchado, Matthew J Bott, et al.
Thrombosis Research|June 30, 2016
D-dimer levels and recurrence in patients with unprovoked VTE and a negative qualitative D-dimer test after treatmentC Kearon, S Parpia, F A Spencer, et al.
The New England Journal of Medicine|August 15, 2003
Comparison of low-intensity warfarin therapy with conventional-intensity warfarin therapy for long-term prevention of recurrent venous thromboembolismClive Kearon, Jeffrey S Ginsberg, Michael J Kovacs, et al.
Pageof 61